Phase 1a Study of TU7710 Following Single Dose Administration in Warfarin Anti-coagulated Healthy Male Subjects
Conditions:   Hemophilia A;   Hemophilia B;   Blood Coagulation Disorders Interventions:   Drug: TU7710;   Drug: Normal saline Sponsor:   TiumBio Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects
Conditions:   Hemophilia A;   Hemophilia B;   Blood Coagulation Disorders Interventions:   Drug: TU7710;   Drug: Normal saline Sponsor:   TiumBio Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Conditions:   Antiphospholipid Syndrome;   Ischemic Stroke;   Transient Ischemic Attack;   Cerebrovascular Disease;   Cardiovascular Diseases;   Major Bleed Interventions:   Drug: Antiplatelet Drug;   Drug: Warfarin Sponsors:   Seoul National University Hospital;   Samjin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials